The results appear to surpass those seen with Merck \u0026 Co Inc\u0027s pill, molnupiravir, which was shown last month to halve the likelihood of dying or being…
Pfizer shares surged 13% to $49.47, while those of Merck fell 6% to $84.69.'Maybe it's great — we just have no idea': Will Merck's anti-COVID pill live up to the hype?
The planned analysis of 1,219 patients in Pfizer’s study looked at hospitalizations or deaths among people diagnosed with mild to moderate COVID-19 with at least one risk factor for developing severe disease, such as obesity or older age. Antivirals need to be given as early as possible, before an infection takes hold, in order to be most effective. Merck tested its drug within five days of symptom onset.
“These data suggest that our oral antiviral candidate, if approved by regulatory authorities, has the potential to save patients’ lives, reduce the severity of COVID-19 infections, and eliminate up to nine out of ten hospitalizations,” Pfizer Chief Executive Albert Bourla said in a statement.Article content
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Canada making 'good progress' in slowing growth of COVID-19 pandemic: TamCanada's top doctor says while Canada has made 'good progress' in slowing the growth of the COVID-19 pandemic across most of the country, the rate of decline has 'slowed somewhat.'
Read more »
COVID-19 cases declining across Canada, but not as quickly as beforeCases of COVID-19 are declining across Canada, but not as quickly as before. Dr. Theresa Tam says Canada could still see some ‘bumps in the trajectory’ over the next few months
Read more »
Indians celebrate festival of light amid COVID-19 fearsIndians across the country began celebrating Diwali, the Hindu festival of lights, on Thursday amid concerns over the coronavirus pandemic and rising air pollution.
Read more »
COVID-19: Concern mounts over fake vaccine exemption letters in B.C. | Globalnews.caHealth officials are voicing concern over doctors offering potentially-fraudulent vaccine exemptions as COVID-19 restrictions remain in place.
Read more »